Prescribing and sale of ophthalmic chloramphenicol following reclassification to over-the-counter availability

International Journal of Pharmacy Practice

Volumn 18, Issue 5, 2010, Pages 269-274

  Walker, Roger ^a,b   Hinchliffe, Anne ^a  

^a PUBLIC HEALTH WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

chloramphenicol; conjunctivitis; over the counter; pharmacosurveillance

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; DIBROMPROPAMIDINE; EYE OINTMENT; FUSIDIC ACID; GENTAMICIN; LEVOFLOXACIN; NEOMYCIN; NON PRESCRIPTION DRUG; OFLOXACIN; POLYMYXIN B; PROPAMIDINE; ANTIINFECTIVE AGENT;

ARTICLE; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; UNITED KINGDOM; CONJUNCTIVITIS; DRUG UTILIZATION; HUMAN; RETROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; CHLORAMPHENICOL; CONJUNCTIVITIS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; ENGLAND; HUMANS; NONPRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; WALES;

EID: 77956443166     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/ijpp.18.05.00046.x     Document Type: Article

References (9)

1. Martin J. British National Formulary, 57th edn. London : British Medical Association, Royal Pharmaceutical Society of Great Britain, 2009.
2. Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis. Cochrane systematic review and meta-analysis update. Br J Gen Pract 2005 55 : 962 964.
3. Medicines and Healthcare Products Regulatory Agency. The reclassification of chloramphenicol eye drops. ARM 25. 2004. http://www.mhra.gov.uk/ Publications/Consultations/Medicinesconsultations/ARMs/CON007689 (accessed 13 April 2010).
4. Walker R, Hinchliffe A. Impact of the reclassification of chloramphenicol eye drops and ointment on prescriptions for chloramphenicol. Int J Pharm Pract 2009 17 : B67 B68.
5. Office of National Statistics. Population estimates mid-2006 UK, England and Wales, Scotland and Northern Ireland. 2007. http://www.statistics.gov.uk/ statbase/Product.asp?vlnk=15106 (accessed 13 April 2010).
6. Denniston A, Murray P. Oxford Handbook of Ophthalmology. Oxford : Oxford University Press, 2006.
7. Ryan M, Yule B. Switching drugs from prescription only to over-the-counter availability; economic benefits in the United Kingdom. Health Policy 1990 16 : 233 239.
8. Dhippayom T, Walker R. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs. Pharm World Sci 2006 28 : 194 198.
9. Department of Health. Building on the Best: Choice, Responsiveness and Equity in the NHS. London : Department of Health, 2003.